Dianthus Therapeutics, Inc. (DNTH) KPIs and segments

DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30

$92.48+3.18 (+3.56%)

Close on Nov 12, 2026Market cap $5.17BP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Dianthus Therapeutics's business

Coming soon

This tab will track the numbers specific to Dianthus Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?